Neuro-Oncology Reviews
Volume
25 Number 15
15 August 2023
Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 15, 15 August
Burge C, Vanguru V, Ho PJ.
Chimeric
antigen receptor T-cell therapy.
Aust
Prescr. 2023 Aug;46(2):36-39∟.
doi: 10.18773/austprescr.2023.003∟.
PMID: 38053567∟.
Review. ˍ
Hsia T, Small JL, Yekula A, Batool
SM, Escobedo AK, Ekanayake E, You DG, Lee H, Carter BS, Balaj
L.
Systematic
Review of Photodynamic Therapy in Gliomas.
Cancers
(Basel). 2023 Aug 1;15(15):3918∟.
doi: 10.3390/cancers15153918∟.
PMID: 37568734∟.
Review. ˍ
Thomas BC, Staudt DE, Douglas AM, Monje M, Vitanza NA, Dun MD.
CAR
T cell therapies for diffuse midline glioma.
Trends
Cancer. 2023 Aug 2:S2405-8033(23)00134-6∟.
doi: 10.1016/j.trecan.2023.07.007∟.
PMID: 37541803∟.
Review. ˍ
Bashir F, Qureshi BM, Minhas K,
Tabori U, Bouffet E, Hawkins C, Enam A, Mushtaq N.
Pakistan
National Guidelines for Pediatric High-Grade Gliomas.
Pak
J Med Sci. 2023 Aug 3;39(5):1548-1554∟.
doi: 10.12669/pjms.39.5.6300∟.
PMID: 37680835∟.
Guidelines. ˍ
Li G, Xu X, Cui J, Zhang F, Wang
S.
Efficacy
of apatinib combined with temozolomide in the treatment of
recurrent high-grade glioma: A meta-analysis.
Exp
Ther Med. 2023 Aug 3;26(3):452∟.
doi: 10.3892/etm.2023.12151∟.
PMID: 37614429∟.
Meta-analysis. ˍ
Mentis AA, Papavassiliou KA, Piperi
C, Papavassiliou AG.
How
can cancer research be illuminated by brain research (and vice
versa)?
Int J
Cancer. 2023 Aug 3∟.
doi: 10.1002/ijc.34682∟.
PMID: 37534858∟.
Perspective˰ ˍ
Kao TJ, Lin CL, Yang WB, Li HY, Hsu TI.
Dysregulated
lipid metabolism in TMZ-resistant glioblastoma: pathways,
proteins, metabolites and therapeutic opportunities.
Lipids
Health Dis. 2023 Aug 3;22(1):114∟.
doi: 10.1186/s12944-023-01881-5∟.
PMID: 37537607∟.
Review. ˍ
Leary SES, Onar-Thomas A, Fangusaro
J, Gottardo NG, Cohen K, Smith A, Huang A, Haas-Kogan D, Fouladi
M; COG Central Nervous System Committee.
Children's
Oncology Group's 2023 blueprint for research: Central nervous
system tumors.
Pediatr
Blood Cancer. 2023 Aug 3:e30600∟.
doi: 10.1002/pbc.30600∟.
PMID: 37534382∟.
Guidelines˰ ˍ
Qi Y, Xiong W, Chen Q, Ye Z, Jiang C, He Y, Ye Q.
New
trends in brain tumor immunity with the opportunities of lymph
nodes targeted drug delivery.
J
Nanobiotechnology. 2023 Aug 4;21(1):254∟.
doi: 10.1186/s12951-023-02011-0∟.
PMID: 37542241∟.
Review. ˍ
Segura PP, Quintela NV, García
MM, Del Barco Berrón S, Sarrió RG, Gómez JG,
Castaño AG, Martín LMN, Rubio OG, Losada
EP.
SEOM-GEINO
clinical guidelines for high-grade gliomas of adulthood
(2022).
Clin
Transl Oncol. 2023 Aug 4;25(9):2634-2646∟.
doi: 10.1007/s12094-023-03245-y∟.
PMID: 37540408∟.
Guidelines. ˍ
Choi H, Kim TG, Jeun SS, Ahn S.
Human
gamma-delta (γδ) T cell therapy for glioblastoma: A
novel alternative to overcome challenges of adoptive immune cell
therapy.
Cancer Lett.
2023 Aug 5:216335∟.
doi: 10.1016/j.canlet.2023.216335∟.
PMID: 37544475∟.
Review˰ ˍ
Cecchi N, Romanelli R, Ricevuti F,
Amitrano M, Carbone MG, Dinardo M, Burgio E.
Current
knowledges in pharmaconutrition: "Ketogenics"
in
pediatric gliomas.
Front
Nutr. 2023 Aug 8;10:1222908∟.
doi: 10.3389/fnut.2023.1222908∟.
PMID: 37614745∟.
Review. ˍ
Kas A, Rozenblum L, Pyatigorskaya
N.
Clinical
Value of Hybrid PET/MR Imaging: Brain Imaging Using PET/MR
Imaging.
Magn
Reson Imaging Clin N Am. 2023 Aug 8;31(4):591-604∟.
doi: 10.1016/j.mric.2023.06.004∟.
PMID: 37741643∟.
Review˰ ˍ
Prados MD.
Current
Strategies for Management of Medulloblastoma.
Diagnostics
(Basel). 2023 Aug 8;13(16):2622∟.
doi: 10.3390/diagnostics13162622∟.
PMID: 37627881∟.
Review. ˍ
Spallone A.
Editorial:
Modern neurosurgical management of gliomas, including local
therapies.
Front
Oncol. 2023 Aug 8;13:1217180∟.
doi: 10.3389/fonc.2023.1217180∟.
PMID: 37614507∟.
Editorial. ˍ
Lin S, Li K, Qi L.
Cancer
stem cells in brain tumors: From origin to clinical
implications.
MedComm
(2020). 2023 Aug 9;4(4):e341∟.
doi: 10.1002/mco2.341∟.
PMID: 37576862∟.
Review. ˍ
Farhat M, Fuller GN, Wintermark M,
Chung C, Kumar VA, Chen M.
Multifocal
and multicentric glioblastoma: Imaging signature, molecular
characterization, patterns of spread, and treatment.
Neuroradiol
J. 2023 Aug 10:19714009231193162∟.
doi: 10.1177/19714009231193162∟.
PMID: 37559514∟.
Review. ˍ
Mier-García JF, Ospina-Santa
S, Orozco-Mera J, Ma R, Plaha P.
Supramaximal
versus gross total resection in Glioblastoma, IDH wild-type and
Astrocytoma, IDH-mutant, grade 4, effect on overall and
progression free survival: systematic review and meta-analysis.
J
Neurooncol. 2023 Aug 10∟.
doi: 10.1007/s11060-023-04409-0∟.
PMID: 37561356∟.
Review, Meta-analysis˰ ˍ
Parveen R, Harihar D, Chatterji BP.
Recent
histone deacetylase inhibitors in cancer therapy.
Cancer.
2023 Aug 10∟.
doi: 10.1002/cncr.34974∟.
PMID: 37560925∟.
Review˰ ˍ
In A, Stopa BM, Cuoco JA, Stump MS,
Apfel LS, Rogers CM.
Central
nervous system lymphoproliferative disorder secondary to
methotrexate: A systematic literature review and case
illustration.
World
Neurosurg. 2023 Aug 12:S1878-8750(23)01120-8∟.
doi: 10.1016/j.wneu.2023.08.018∟.
PMID: 37574195∟.
Case report, Review˰ ˍ
Miguel Llordes G, Medina Pérez
VM, Curto Simón B, Castells-Yus I, Vázquez Sufuentes
S, Schuhmacher AJ.
Epidemiology,
Diagnostic Strategies, and Therapeutic Advances in Diffuse Midline
Glioma.
J Clin
Med. 2023 Aug 12;12(16):5261∟.
doi: 10.3390/jcm12165261∟.
PMID: 37629304∟.
Review. ˍ
Price G, Rossitto C, Price H,
Hadjipanayis C, Martini M.
Trends
in Immunotherapy Clinical Trials to Treat Glioblastoma: A Look at
Progress and Challenges.
World
Neurosurg. 2023 Aug 12:S1878-8750(23)01121-X∟.
doi: 10.1016/j.wneu.2023.08.020∟.
PMID: 37574192∟.
Review˰ ˍ
Castresana JS, Meléndez
B.
Glioblastoma
Biology, Genetics and Possible Therapies.
Cells.
2023 Aug 14;12(16):2063∟.
doi: 10.3390/cells12162063∟.
PMID: 37626873∟.
Editorial. ˍ
Duan ZH, Wei ZL.
Research
Progress in Immunotherapy of Gliomas.
J
Integr Neurosci. 2023 Aug 14;22(5):118∟.
doi: 10.31083/j.jin2205118∟.
PMID: 37735122∟.
Review. ˍ
Heuer S, Winkler F.
Glioblastoma
revisited: from neuronal-like invasion to pacemaking.
Trends
Cancer. 2023 Aug 14:S2405-8033(23)00136-X∟.
doi: 10.1016/j.trecan.2023.07.009∟.
PMID: 37586918∟.
Perspective˰ ˍ
Wang JH, Kiess AP.
PSMA-targeted
therapy for non-prostate cancers.
Front
Oncol. 2023 Aug 14;13:1220586∟.
doi: 10.3389/fonc.2023.1220586∟.
PMID: 37645427∟.
Review. ˍ
Baddam S, Kalagara S, Krishna K,
Enaganti S.
Recent
advancements and theranostics strategies in glioblastoma
therapy.
Biomed
Mater. 2023 Aug 15∟.
doi: 10.1088/1748-605X/acf0ab∟.
PMID: 37582381∟.
Review˰ ˍ
Bel'skaya LV, Sarf EA, Loginova
AI.
Diagnostic
Value of Salivary Amino Acid Levels in Cancer.
Metabolites.
2023 Aug 15;13(8):950∟.
doi: 10.3390/metabo13080950∟.
PMID: 37623893∟.
Review. ˍ
Meenakshi S, Maharana KC, Nama L,
Kumar VU, Dhingra S, Ravichandiran V, Murti K, Kumar N.
Targeting
Histone 3 Variants Epigenetic Landscape and Inhibitory Immune
Checkpoints: An Option for Paediatric Brain Tumours Therapy.
Curr
Neuropharmacol. 2023 Aug 15∟.
doi: 10.2174/1570159X21666230809110444∟.
PMID: 37605389∟.
Review˰ ˍ
*
Shoaib F, Furrukh M, Mushtaq F,
Sayeed S, Nasir H, Ghafoor H.
Extra
Neural Metastasis Of Glioblastoma Multiforme: A Literature
Review.
J Pak
Med Assoc. 2023 Aug 15;73(9):1869-1873∟.
doi: 10.47391/JPMA.7694∟.
PMID: 37817700∟.
Review. ˍ